Nomura Holdings Inc Biomarin Pharmaceutical Inc Transaction History

Nomura Holdings Inc

$47 Billion
Q1 2025

A detailed history of Nomura Holdings Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nomura Holdings Inc holds 92,390 shares of BMRN stock, worth $5.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

92,390

Previous 126,842 27.16%

Holding current value

$5.43 Million

Previous $8.34 Million 21.66%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$61.25 - $72.83 $2.11 Million - $2.51 Million	-34,452 Reduced 27.16%	92,390 $6.53 Million
Q4 2024 Feb 14, 2025	BUY	$61.93 - $70.49 $7.86 Million - $8.94 Million	126,842 New	126,842 $8.34 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $125 Million - $148 Million	1,491,255 New	1,491,255 $130 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $54 Million - $69.7 Million	-707,873 Reduced 24.92%	2,132,937 $206 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $242 Million - $268 Million	2,840,810 New	2,840,810 $251 Million
Q3 2022 Nov 15, 2022	BUY	$82.16 - $96.94 $15.8 Million - $18.7 Million	192,653 Added 2408.16%	200,653 $17 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $571,840 - $694,800	8,000 New	8,000 $680,000
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $429,244 - $547,447	-5,985 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $144,679 - $165,384	-1,935 Reduced 24.43%	5,985 $463,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $1.64 Million - $1.84 Million	-21,738 Reduced 73.3%	7,920 $661,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $1.19 Million - $1.44 Million	-15,895 Reduced 34.89%	29,658 $2.24 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $1.42 Million - $1.76 Million	-19,536 Reduced 30.01%	45,553 $3.99 Million
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $10.6 Million - $19.4 Million	-147,784 Reduced 69.42%	65,089 $4.96 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $13.4 Million - $21 Million	168,884 Added 383.92%	212,873 $26.2 Million
Q1 2020 May 14, 2020	SELL	$71.37 - $96.85 $1.27 Million - $1.72 Million	-17,811 Reduced 28.82%	43,989 $3.71 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $1.79 Million - $2.4 Million	-27,799 Reduced 31.03%	61,800 $5.22 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $5.73 Million - $7.24 Million	-85,077 Reduced 48.71%	89,599 $5.8 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.39 Million - $1.63 Million	17,358 Added 11.03%	174,676 $14.7 Million
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $4.19 Million - $4.91 Million	49,763 Added 46.27%	157,318 $14.1 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $526,359 - $696,667	-6,568 Reduced 5.76%	107,555 $9.16 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $4.79 Million - $5.4 Million	-51,044 Reduced 30.9%	114,123 $11.3 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $11.7 Million - $15.2 Million	153,776 Added 1349.98%	165,167 $12.1 Million
Q1 2018 May 14, 2018	BUY	$77.67 - $92.63 $884,738 - $1.06 Million	11,391 New	11,391 $922,000
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $1.6 Million - $1.88 Million	-19,762 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $1.59 Million - $1.88 Million	19,762	19,762 $1.84 Million

Others Institutions Holding BMRN

# of Institutions

670

Shares Held

185M

Call Options Held

1.25M

Put Options Held

992K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.9B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Biomarin Pharmaceutical Inc Transaction History